JACC. Case reports · 2026
Pseudo-Ischemic ECG Changes in a Patient With Profound Mixed Metabolic Acidosis Due to Metformin Use.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Grant John J, Wilson David P, Schindler John T
Аннотация
BACKGROUND: Metformin-induced lactic acidosis can cause electrocardiographic (ECG) changes and precipitate cardiac arrest.
CASE SUMMARY: A 58-year-old woman presented to the emergency department after a ventricular fibrillation arrest. Laboratory findings on admission showed severe lactic acidosis, and ECG showed ischemic changes concerning for a ST-segment elevation myocardial infarction. After treatment of the patient's sepsis, urinary tract infection, and acute kidney injury, she improved, and the pseudo-ischemic ECG changes resolved.
DISCUSSION: Metformin is a known instigator of lactic acidosis, particularly in patients with renal failure. On rare occasion, such lactic acidosis secondary to metformin can produce lethal arrhythmias. This case demonstrates the need for providers to consider metabolic derangements in patients with ventricular fibrillation arrest and subsequent ECG changes.
TAKE-HOME MESSAGE: It is crucial for providers to recognize metabolic acidosis as a precipitator of cardiac arrest and to identify patients who take metformin who are at risk for metformin-associated lactic acidosis.
CASE SUMMARY: A 58-year-old woman presented to the emergency department after a ventricular fibrillation arrest. Laboratory findings on admission showed severe lactic acidosis, and ECG showed ischemic changes concerning for a ST-segment elevation myocardial infarction. After treatment of the patient's sepsis, urinary tract infection, and acute kidney injury, she improved, and the pseudo-ischemic ECG changes resolved.
DISCUSSION: Metformin is a known instigator of lactic acidosis, particularly in patients with renal failure. On rare occasion, such lactic acidosis secondary to metformin can produce lethal arrhythmias. This case demonstrates the need for providers to consider metabolic derangements in patients with ventricular fibrillation arrest and subsequent ECG changes.
TAKE-HOME MESSAGE: It is crucial for providers to recognize metabolic acidosis as a precipitator of cardiac arrest and to identify patients who take metformin who are at risk for metformin-associated lactic acidosis.